Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatitis

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2018

Primary Completion Date

January 1, 2023

Study Completion Date

May 22, 2023

Conditions
Alcoholic Hepatitis
Interventions
DIETARY_SUPPLEMENT

Omega 5 fatty acid supplement

Patients will be randomized to receive traditional treatment (prednisone 40 mg per day) plus omega 5 fatty acid ( 2 capsules of 0.64g per day) for 28 days.

OTHER

PLACEBO

Patients will be randomized to receive the traditional treatment (prednisone 40 mg per day) plus placebo (2 capsules of placebo with identical appereance and size like omega 5 supplement) for 28 days.

Trial Locations (2)

14080

Hospital General Dr. Manuel Gea Gonzalez, Mexico City

06720

Laboratorio de Higado, Pancreas y Motilidad Intestinal. UNIVERSIDAD AUTONOMA DE MEXICO, Mexico City

All Listed Sponsors
collaborator

Universidad Nacional Autonoma de Mexico

OTHER

lead

Hospital General Dr. Manuel Gea González

OTHER_GOV

NCT03732586 - Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter